NORTHERN TRUST CORP - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$137,228
-25.4%
20,2700.0%0.00%
Q2 2023$184,052
+40.4%
20,270
-0.1%
0.00%
Q1 2023$131,119
+8.2%
20,297
+6.2%
0.00%
Q4 2022$121,132
+2.7%
19,1060.0%0.00%
Q3 2022$118,000
-30.2%
19,1060.0%0.00%
Q2 2022$169,000
+0.6%
19,106
-4.0%
0.00%
Q1 2022$168,000
-17.2%
19,9050.0%0.00%
Q4 2021$203,000
-53.0%
19,905
-10.4%
0.00%
Q3 2021$432,000
+76.3%
22,221
+59.3%
0.00%
Q2 2021$245,000
+47.6%
13,9490.0%0.00%
Q1 2021$166,000
-22.1%
13,949
+12.7%
0.00%
Q4 2020$213,00012,3740.00%
Other shareholders
INMUNE BIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 178,284$1,219,4630.13%
Fermata Advisors, LLC 56,702$383,8880.11%
Westside Investment Management, Inc. 41,540$281,2270.08%
QUADRANT CAPITAL GROUP LLC 60,000$406,2000.04%
MAI Capital Management 97,410$659,4660.01%
Janney Montgomery Scott LLC 256,887$1,7390.01%
Financial Advocates Investment Management 11,510$78,3200.01%
VALLEY NATIONAL ADVISERS INC 1,000$70.00%
Beacon Pointe Advisors, LLC 10,368$70,1910.00%
Asset Dedication, LLC 814$60.00%
View complete list of INMUNE BIO INC shareholders